CEDIC
Caba, Buenos Aires, Argentina
Medical office in Buenos Aires
Av. Santa Fe 1480 1° Piso, C1060 CABA
About CEDIC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
7
Pfizer
2
Clinical Trials at CEDIC
During the past decade, CEDIC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
2020-08-04
2024-05-24
Active, not recruiting
2,539
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
2020-07-01
2021-10-08
Completed
278
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
2021-03-29
2023-05-17
Active, not recruiting
750
A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
2022-08-11
2024-03-01
Recruiting
670
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
2022-08-12
2024-05-06
Active, not recruiting
692
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at CEDIC
According to Clinical.Site data, the most researched conditions in "CEDIC" are
"Obesity" (3 trials), "Overweight" (3 trials), "Cardiovascular Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "CEDIC" in a lesser frequency.
Clinical Trials Intervention Types at CEDIC
Most popular intervention types in "CEDIC" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (4 trials), "Insulin Degludec" (2 trials), "Insulin Efsitora Alfa" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CEDIC
The vast majority of trials in "CEDIC" are
9 trials for "All" genders.
Clinical Trials Status at CEDIC
Currently, there are NaN active trials in "CEDIC".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CEDIC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in CEDIC, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".